NCT02004678View on ClinicalTrials.gov

Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

DS-1150b

OTHER

Placebo

Trial Locations (1)

Unknown

Clinical Pharmacology of Miami, Inc., Miami

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY